Logo image of CCM

CONCORD MEDICAL - SPON ADR (CCM) Stock Earnings & Estimates

NYSE:CCM - US2062772049 - ADR

5.45 USD
-0.09 (-1.64%)
Last: 8/28/2025, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
CCM revenue by date.CCM revenue by date.
472.085M
-2.78%
537M
13.75%
384M
-28.49%
EBITDA
YoY % growth
CCM ebitda by date.CCM ebitda by date.
-392.234M
-10.74%
-381.36M
2.77%
-447M
-17.21%
EBIT
YoY % growth
CCM ebit by date.CCM ebit by date.
-525.048M
-14.56%
-463.36M
11.75%
-532M
-14.81%
Operating Margin
CCM operating margin by date.CCM operating margin by date.
-111.22%-86.29%-138.54%
EPS
YoY % growth
CCM eps by date.CCM eps by date.
N/AN/AN/A

All data in CNY

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CNY

Recent Earnings VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
CCM Yearly EPS VS EstimatesCCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0 2 -2 4 -4 -6
Recent Revenue VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
165M
-34.78%
%
Q2 2024
Q2Q % growth
219M
-23.03%
%
Q4 2023
Q2Q % growth
253M
-22.82%
%
Q2 2023
Q2Q % growth
284.513M
97.22%
%
Q4 2022
Q2Q % growth
327.823M
11.98%
%
Q2 2022
Q2Q % growth
144.262M
-25.21%
%
Q4 2021
Q2Q % growth
292.746M
109.10%
%
Q2 2021
Q2Q % growth
192.887M
132.36%
%
Q4 2020
Q2Q % growth
140M
41.63%
%
Q2 2020
Q2Q % growth
83.011M
-16.58%
%
CCM Yearly Revenue VS EstimatesCCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A